Research Calls II
-
Upgrades:
- Beam Therapeutics (BEAM) upgraded to Overweight from Neutral at Cantor Fitzgerald
- Open Lending (LPRO) upgraded to Buy from Hold at Needham; tgt $7
- Nextracker (NXT) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $60
- Sanmina (SANM) upgraded to Neutral from Underperform at BofA Securities; tgt raised to $92
- Western New England Bancorp (WNEB) upgraded to Buy from Neutral at Seaport Research Partners; tgt $11
-
Downgrades:
- Apple (AAPL) downgraded to Perform from Outperform at Oppenheimer
- DarioHealth (DRIO) downgraded to Hold from Buy at TD Cowen; tgt lowered to $1
- Galiano Gold (GAU) downgraded to Market Perform from Outperform at BMO Capital Markets
- Infosys (INFY) downgraded to Hold from Buy at Erste Group
- Paragon 28 (FNA) downgraded to Mkt Perform from Outperform at William Blair
- Royal Bank of Canada (RY) downgraded to Hold from Buy at Erste Group
-
Others:
- Larimar Therapeutics (LRMR) initiated with a Buy at Truist; tgt $18
- OnKure Therapeutics (OKUR) initiated with a Buy at JonesResearch
- Spotify (SPOT) resumed with a Buy at Erste Group